Both in Pharmaceuticals
Climb Bio vs CytomX Therapeutics
Over the past year CLYM returned +370.5% and CTMX returned −30.1%; their daily moves had a correlation of 0.33.
CLYM +370.5% CTMX −30.1%Growth of $1, one year, split-adjusted
| Metric | CLYM | CTMX |
|---|---|---|
| Price | $9.88 | $2.35 |
| Market cap | $567.5M | $512.1M |
| Today | +3.24% | +1.73% |
| 1 month | −14.1% | −14.5% |
| 6 months | +12.5% | −42.0% |
| Year to date | +147.0% | −44.8% |
| 1 year | +370.5% | −30.1% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.0× |
| Net cash | $183.1M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 83.3% | 67.0% |
| Short % of float | 25.6% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).